About this trial
This study aims to compare the clinical outcomes of debridement, antibiotics, and implant retention (DAIR) and implant removal/replacement methods used in the treatment of fracture-related infections, and to determine the infection-free fracture healing rates and the factors affecting treatment success.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
internal fixation after fracture
presence of fistula and/or sinus tract or purulent drainage with dehiscence at the incision site
at least 2 positive deep tissue cultures or at least 3 positive soft tissue cultures
early onset of symptoms (6 weeks)
Disqualifiers
Under 18 years old patients
prosthetic joint infection
only conservative treatment applied
pathological fracture due to primary bone tumor
Trial population
The study planned to include over 18 years old patients who underwent internal fixation after fracture, had a fistula and/or sinus tract, or purulent drainage with incision dehiscence, at least 2 positive deep tissue cultures or at least 3 positive soft tissue cultures, whose findings started early (6 weeks), and who underwent DAIR or implant removal/replacement due to fracture-related infection.
Trial design
Case-only
Retrospective
Treatments tested in this trial
DAIR
Other interventionDAIR: Debridement, antibiotic retention and implant removal
Implant removal/replacement
Other interventionimplant removal/replacement
Treatment groups
Trial outcomes
Primary outcomes
Fracture healing rates
Infection-free fracture healing rates
Secondary outcomes
Recurrence rate
Infection recurrence rate
Union time
Time to union
Sponsors and contacts
Click on the lead sponsor to view all of their trials.